PlainPharmaWatch

CMS Open Payments · Tool

Celgene Corporation vs Zimmer Biomet Holdings, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Celgene Corporation has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 5,254, versus 1,031 for the other company. Its single largest recorded recipient represents 0.7% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Celgene Corporation
HHI 5,254 · top recipient 0.7%
Ranked #323 of 1,838 companies by HHI
Zimmer Biomet Holdings, Inc.
HHI 1,031 · top recipient 0.3%
Ranked #1,018 of 1,838 companies by HHI

Payment Overview

Total Payments
$88.9M
% of Industry
0.6%
Transactions
62,972
Avg per Transaction
$1.4K
Recipients
60,850
Avg per Recipient
$1.5K
Payment Types
7
Top Payment Type
Royalty or License
Total Payments
$88.6M
% of Industry
0.6%
Transactions
34,372
Avg per Transaction
$2.6K
Recipients
33,496
Avg per Recipient
$2.6K
Payment Types
11
Top Payment Type
Acquisitions

Highlighted values indicate the higher figure for each metric.

Total payments compared

Celgene Corporation vs Zimmer Biomet Holdings, Inc. - total reported payments in CMS Open Payments PY2024

Celgene Corporation$88.9MZimmer Biomet Holdings, Inc.$88.6M

Payment Types Breakdown

Celgene Corporation

Royalty or License $7.7M

8.7%

Food and Beverage $1.3M

1.4%

Compensation for Services Other Than Consulting $632.0K

0.7%

Travel and Lodging $464.5K

0.5%

Consulting Fee $405.1K

0.5%

Grant $128.0K

0.1%

Zimmer Biomet Holdings, Inc.

Acquisitions $40.1M

45.3%

Royalty or License $27.9M

31.5%

Education $6.4M

7.2%

Consulting Fee $4.8M

5.4%

Travel and Lodging $2.2M

2.5%

Food and Beverage $1.4M

1.6%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Celgene Corporation

  1. 1

    Seattle Childrens Hospital

    $7,718,018.00 · 5 txns

  2. 2

    Dana-Farber Cancer Institute

    $314,119.50 · 3 txns

  3. 3

    University Of Kansas Hospital

    $103,933.00 · 13 txns

  4. 4

    Langley Porter Psychiatric Hospital

    $89,159.14 · 1 txns

  5. 5

    Hospital Of The Univ Of Penna

    $75,000.00 · 1 txns

Zimmer Biomet Holdings, Inc.

  1. 1

    NITIN GOYAL

    $25,000,264.39 · 6 txns

  2. 2

    ERIK KUBIAK

    $7,390,410.50 · 7 txns

  3. 3

    COLIN POOLE

    $3,199,557.39 · 2 txns

  4. 4

    AARON HOFMANN

    $2,593,980.00 · 1 txns

  5. 5

    JONATHAN YERASIMIDES

    $1,925,363.72 · 181 txns

Summary Comparison

Metric Celgene Corporation Zimmer Biomet Holdings, Inc.
Total Payments $88.9M $88.6M
% of Industry Total 0.6% 0.6%
Transaction Count 62,972 34,372
Avg per Transaction $1.4K $2.6K
Recipient Count 60,850 33,496
Avg per Recipient $1.5K $2.6K
Payment Type Count 7 11
Top Payment Type Royalty or License Acquisitions

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.